Title:
NON-CLINICAL TEST METHOD CHARACTERIZED BY QUANTITATIVE EVALUATION OF EXPERIMENTAL ANIMAL SPECIMEN
Document Type and Number:
WIPO Patent Application WO/2017/141987
Kind Code:
A1
Abstract:
Provided is a non-clinical test method characterized by including a step for: performing quality control of an experimental animal, such as a tumor-bearing mouse, having a transplanted tumor site, or another experimental animal having a lesion site; or specifying a profile of a lesion site, for example a transplanted tumor site of an experimental animal, by a quantitative technique, using a specimen collected from such an experimental animal.
Inventors:
GOUDA HIDEKI (JP)
SHIRAISHI TAKESHI (JP)
ISODA TAKESHI (JP)
KOYAMA NOBORU (JP)
OKADA HISATAKE (JP)
SHIRAISHI TAKESHI (JP)
ISODA TAKESHI (JP)
KOYAMA NOBORU (JP)
OKADA HISATAKE (JP)
Application Number:
PCT/JP2017/005588
Publication Date:
August 24, 2017
Filing Date:
February 15, 2017
Export Citation:
Assignee:
KONICA MINOLTA INC (JP)
International Classes:
G01N33/574; C12Q1/02; G01N33/48; G01N33/53; G01N33/543
Domestic Patent References:
| WO2007049620A1 | 2007-05-03 | |||
| WO2012029752A1 | 2012-03-08 | |||
| WO2013035703A1 | 2013-03-14 | |||
| WO2008001614A1 | 2008-01-03 | |||
| WO2007058021A1 | 2007-05-24 | |||
| WO2012029752A1 | 2012-03-08 | |||
| WO2013035703A1 | 2013-03-14 |
Foreign References:
| JP2008169132A | 2008-07-24 | |||
| JP2007274950A | 2007-10-25 | |||
| JP2014510075A | 2014-04-24 |
Other References:
See also references of EP 3418744A4
JAGER ET AL.: "Patient-derived bladder cancer xenografts in the preclinical development of novel target therapies", ONCOTARGET, vol. 6, no. 25, pages 21522 - 21532
KOHRT ET AL.: "Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies", ANNALS OF ONCOLOGY, vol. 00, 2016, pages 1 - 9
PROC. NATL. ACAD. SCI. USA, vol. 89, June 1992 (1992-06-01), pages 5645 - 5649
JAGER ET AL.: "Patient-derived bladder cancer xenografts in the preclinical development of novel target therapies", ONCOTARGET, vol. 6, no. 25, pages 21522 - 21532
KOHRT ET AL.: "Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies", ANNALS OF ONCOLOGY, vol. 00, 2016, pages 1 - 9
PROC. NATL. ACAD. SCI. USA, vol. 89, June 1992 (1992-06-01), pages 5645 - 5649
Attorney, Agent or Firm:
SSINPAT PATENT FIRM (JP)
Download PDF: